Heartflow, Inc. Terminates Material Definitive Agreement
Ticker: HTFL · Form: 8-K · Filed: Aug 25, 2025 · CIK: 1464521
| Field | Detail |
|---|---|
| Company | Heartflow, Inc. (HTFL) |
| Form Type | 8-K |
| Filed Date | Aug 25, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $60.1 million, $1.0 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, 8-k
TL;DR
Heartflow terminated a key deal on 8/22. Big changes ahead?
AI Summary
Heartflow, Inc. filed an 8-K on August 25, 2025, reporting the termination of a material definitive agreement as of August 22, 2025. The company, formerly known as Cardiovascular Simulation, Inc., is incorporated in Delaware and headquartered in Mountain View, California.
Why It Matters
The termination of a material definitive agreement can signal significant changes in a company's operations, partnerships, or financial arrangements, potentially impacting its future business trajectory.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement can indicate underlying issues or strategic shifts that carry inherent business risks.
Key Numbers
- 001-42790 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-0506743 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Heartflow, Inc. (company) — Registrant
- August 22, 2025 (date) — Date of earliest event reported
- August 25, 2025 (date) — Date of Report
- Cardiovascular Simulation, Inc. (company) — Former Name
- Delaware (jurisdiction) — State of Incorporation
- Mountain View, California (location) — Principal Executive Offices
FAQ
What was the specific material definitive agreement that was terminated?
The filing does not specify the exact agreement terminated, only that a material definitive agreement was terminated as of August 22, 2025.
What is the reason for the termination of the material definitive agreement?
The filing does not provide the reason for the termination of the material definitive agreement.
When was the termination effective?
The termination was effective as of August 22, 2025.
What is Heartflow, Inc.'s principal business?
Heartflow, Inc. is in the Surgical & Medical Instruments & Apparatus industry (SIC code 3841).
Has Heartflow, Inc. changed its name previously?
Yes, Heartflow, Inc. was formerly known as Cardiovascular Simulation, Inc., with a name change date of May 19, 2009.
Filing Stats: 523 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2025-08-25 16:03:57
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share HTFL The Nasdaq Sto
- $60.1 million — rising an aggregate principal amount of $60.1 million plus accrued interest of $1.0 million,
- $1.0 m — $60.1 million plus accrued interest of $1.0 million, under that certain Credit Agreem
Filing Documents
- htfl-20250822.htm (8-K) — 24KB
- 0001464521-25-000005.txt ( ) — 140KB
- htfl-20250822.xsd (EX-101.SCH) — 2KB
- htfl-20250822_lab.xml (EX-101.LAB) — 22KB
- htfl-20250822_pre.xml (EX-101.PRE) — 13KB
- htfl-20250822_htm.xml (XML) — 3KB
02 Termination of a Material Definitive Agreement
Item 1.02 Termination of a Material Definitive Agreement. On August 22, 2025, Heartflow, Inc. (the "Company") prepaid in full all outstanding amounts, comprising an aggregate principal amount of $60.1 million plus accrued interest of $1.0 million, under that certain Credit Agreement and Guaranty, dated as of June 14, 2024 and as amended on January 24, 2025 (the "Credit Agreement"), by and among the Company, as borrower, Hayfin Services LLP, as agent ("Hayfin"), and the other parties thereto and, in connection with such prepayment, the Credit Agreement was terminated. The Company did not incur exit or prepayment fees in connection with the termination of the Credit Agreement. Material terms and conditions of the Credit Agreement were summarized under "Management's discussion and analysis of financial condition and results of operations—Liquidity and capital resources—Hayfin credit agreement" in the Company's Registration Statement on Form S-1 filed with the U.S. Securities and Exchange Commission on July 17, 2025, as amended, and such summary is incorporated herein by reference. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEARTFLOW, INC. Date: August 25, 2025 By: /s/ Vikram Verghese Vikram Verghese Chief Financial Officer 3